Ad/Pd 2025. The ad/pd™ alzheimer’s disease and parkinson’s disease conference will present all the latest breakthroughs in treatment, translational r&d, early diagnosis, drug development and clinical. Our groundbreaking series of conferences attract.

Welcome to the ad/pd™ 2025 interactive program. Ad/pd™ conferences uniquely combine distinct neurodegenerative diseases in one setting and examine their similarities and differences;